150 related articles for article (PubMed ID: 28744327)
1. miR-196a Enhances Neuronal Morphology through Suppressing RANBP10 to Provide Neuroprotection in Huntington's Disease.
Her LS; Mao SH; Chang CY; Cheng PH; Chang YF; Yang HI; Chen CM; Yang SH
Theranostics; 2017; 7(9):2452-2462. PubMed ID: 28744327
[TBL] [Abstract][Full Text] [Related]
2. miR-196a enhances polymerization of neuronal microfilaments through suppressing IMP3 and upregulating IGF2 in Huntington's disease.
Yang HI; Huang PY; Chan SC; Tung CW; Cheng PH; Chen CM; Yang SH
Mol Ther Nucleic Acids; 2022 Dec; 30():286-299. PubMed ID: 36320323
[TBL] [Abstract][Full Text] [Related]
3. The Potential Regulatory Mechanisms of miR-196a in Huntington's Disease through Bioinformatic Analyses.
Fu MH; Li CL; Lin HL; Tsai SJ; Lai YY; Chang YF; Cheng PH; Chen CM; Yang SH
PLoS One; 2015; 10(9):e0137637. PubMed ID: 26376480
[TBL] [Abstract][Full Text] [Related]
4. miR-196a ameliorates phenotypes of Huntington disease in cell, transgenic mouse, and induced pluripotent stem cell models.
Cheng PH; Li CL; Chang YF; Tsai SJ; Lai YY; Chan AW; Chen CM; Yang SH
Am J Hum Genet; 2013 Aug; 93(2):306-12. PubMed ID: 23810380
[TBL] [Abstract][Full Text] [Related]
5. miR-196a provides antioxidative neuroprotection via USP15/Nrf2 regulation in Huntington's disease.
Chan SC; Tung CW; Lin CW; Tung YS; Wu PM; Cheng PH; Chen CM; Yang SH
Free Radic Biol Med; 2023 Nov; 209(Pt 2):292-300. PubMed ID: 37907121
[TBL] [Abstract][Full Text] [Related]
6. miR-196a Ameliorates Cytotoxicity and Cellular Phenotype in Transgenic Huntington's Disease Monkey Neural Cells.
Kunkanjanawan T; Carter RL; Prucha MS; Yang J; Parnpai R; Chan AW
PLoS One; 2016; 11(9):e0162788. PubMed ID: 27631085
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs located in the Hox gene clusters are implicated in huntington's disease pathogenesis.
Hoss AG; Kartha VK; Dong X; Latourelle JC; Dumitriu A; Hadzi TC; Macdonald ME; Gusella JF; Akbarian S; Chen JF; Weng Z; Myers RH
PLoS Genet; 2014 Feb; 10(2):e1004188. PubMed ID: 24586208
[TBL] [Abstract][Full Text] [Related]
8. miR-10b-5p expression in Huntington's disease brain relates to age of onset and the extent of striatal involvement.
Hoss AG; Labadorf A; Latourelle JC; Kartha VK; Hadzi TC; Gusella JF; MacDonald ME; Chen JF; Akbarian S; Weng Z; Vonsattel JP; Myers RH
BMC Med Genomics; 2015 Mar; 8():10. PubMed ID: 25889241
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of miR-9* in the peripheral leukocytes of Huntington's disease patients.
Chang KH; Wu YR; Chen CM
Orphanet J Rare Dis; 2017 Dec; 12(1):185. PubMed ID: 29258536
[TBL] [Abstract][Full Text] [Related]
10. High-Throughput Sequencing of BACHD Mice Reveals Upregulation of Neuroprotective miRNAs at the Pre-Symptomatic Stage of Huntington's Disease.
Olmo IG; Olmo RP; Gonçalves ANA; Pires RGW; Marques JT; Ribeiro FM
ASN Neuro; 2021; 13():17590914211009857. PubMed ID: 33906482
[TBL] [Abstract][Full Text] [Related]
11. Modeling brain reserve: experience-dependent neuronal plasticity in healthy and Huntington's disease transgenic mice.
Nithianantharajah J; Barkus C; Vijiaratnam N; Clement O; Hannan AJ
Am J Geriatr Psychiatry; 2009 Mar; 17(3):196-209. PubMed ID: 19454847
[TBL] [Abstract][Full Text] [Related]
12. The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington's disease.
Doria JG; de Souza JM; Andrade JN; Rodrigues HA; Guimaraes IM; Carvalho TG; Guatimosim C; Dobransky T; Ribeiro FM
Neurobiol Dis; 2015 Jan; 73():163-73. PubMed ID: 25160573
[TBL] [Abstract][Full Text] [Related]
13. Treatment with a herbal formula B401 enhances neuroprotection and angiogenesis in the R6/2 mouse model of Huntington's disease.
Wang SE; Lin CL; Hsu CH; Sheu SJ; Chien CT; Wu CH
Drug Des Devel Ther; 2015; 9():887-900. PubMed ID: 25733809
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-196a/-196b promote cell metastasis via negative regulation of radixin in human gastric cancer.
Tsai MM; Wang CS; Tsai CY; Chen CY; Chi HC; Tseng YH; Chung PJ; Lin YH; Chung IH; Chen CY; Lin KH
Cancer Lett; 2014 Sep; 351(2):222-31. PubMed ID: 24933454
[TBL] [Abstract][Full Text] [Related]
15. miR-196a overexpression activates the MEK/ERK signal and represses the progesterone receptor and decidualization in eutopic endometrium from women with endometriosis.
Zhou M; Fu J; Xiao L; Yang S; Song Y; Zhang X; Feng X; Sun H; Xu W; Huang W
Hum Reprod; 2016 Nov; 31(11):2598-2608. PubMed ID: 27619769
[TBL] [Abstract][Full Text] [Related]
16. TGF-β-mediated downregulation of microRNA-196a contributes to the constitutive upregulated type I collagen expression in scleroderma dermal fibroblasts.
Honda N; Jinnin M; Kajihara I; Makino T; Makino K; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
J Immunol; 2012 Apr; 188(7):3323-31. PubMed ID: 22379029
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
Shang Y; Wang LQ; Guo QY; Shi TL
Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752
[TBL] [Abstract][Full Text] [Related]
18. Cellular Transcriptional Coactivator RanBP10 and Herpes Simplex Virus 1 ICP0 Interact and Synergistically Promote Viral Gene Expression and Replication.
Sato Y; Kato A; Maruzuru Y; Oyama M; Kozuka-Hata H; Arii J; Kawaguchi Y
J Virol; 2016 Jan; 90(6):3173-86. PubMed ID: 26739050
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-196a promotes an oncogenic effect in head and neck cancer cells by suppressing annexin A1 and enhancing radioresistance.
Suh YE; Raulf N; Gäken J; Lawler K; Urbano TG; Bullenkamp J; Gobeil S; Huot J; Odell E; Tavassoli M
Int J Cancer; 2015 Sep; 137(5):1021-34. PubMed ID: 25523631
[TBL] [Abstract][Full Text] [Related]
20. MiR-196a Regulates High Glucose-Induced Mesangial Cell Hypertrophy by Targeting p27kip1.
Wang X; Shen E; Wang Y; Jiang Z; Gui D; Cheng D; Chen T; Wang N
J Lab Autom; 2015 Aug; 20(4):491-9. PubMed ID: 25657172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
